Photobiomodulation With REd vs BluE Light (REBEL)
Conditions: Dry Eye Syndromes; Meibomian Gland Dysfunction; Blepharitis Interventions: Device: Red LLLT; Device: Blue LLLT; Device: Sham Red LLLT; Device: Sham Blue LLLT Sponsors: Aston University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation
Conditions: MicroBlepharoexfoliation, NuLids, iTEAR100, iLIDS100, Blepharitis, Dry Eye Syndrome Interventions: Device: iLIDS100 Sponsors: Olympic Ophthalmics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Impact of XDEMVY ® on Demodex Blepharitis in Soft Contact Lens Wearers
Conditions: Demodex Blepharitis Interventions: Drug: Lotilaner ophthalmic solution, 0.25%; Drug: Vehicle control Sponsors: Tarsus Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex
Conditions: Meibomian Gland Dysfunction; Demodex Infestation of Eyelid; Blepharitis; Demodectic Blepharitis Intervention: Drug: Exploratory Vehicle Sponsor: Tarsus Pharmaceuticals, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex
Conditions: Meibomian Gland Dysfunction; Demodex Infestation of Eyelid; Blepharitis; Demodectic Blepharitis Interventions: Drug: Exploratory Vehicle Sponsors: Tarsus Pharmaceuticals, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
0.01% Hypochlorous Acid in the Treatment of Blepharitis
Condition: Blepharitis Interventions: Drug: 0.01% hypochlorous acid; Drug: Placebo Sponsors: Eye & ENT Hospital of Fudan University; ShuGuang Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2022 Category: Research Source Type: clinical trials
